[go: up one dir, main page]

PL2557943T3 - Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki - Google Patents

Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki

Info

Publication number
PL2557943T3
PL2557943T3 PL11715599T PL11715599T PL2557943T3 PL 2557943 T3 PL2557943 T3 PL 2557943T3 PL 11715599 T PL11715599 T PL 11715599T PL 11715599 T PL11715599 T PL 11715599T PL 2557943 T3 PL2557943 T3 PL 2557943T3
Authority
PL
Poland
Prior art keywords
nutraceutical compositions
veterinary pharmaceutical
oral veterinary
oral
pharmaceutical
Prior art date
Application number
PL11715599T
Other languages
English (en)
Inventor
Kurt Ingar Draget
Ingvild Johanne Haug
Steinar Johan Engelsen
Tore Seternes
Original Assignee
Vitux Group As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitux Group As filed Critical Vitux Group As
Publication of PL2557943T3 publication Critical patent/PL2557943T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/195Antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/40Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/60Fish, e.g. seahorses; Fish eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11715599T 2010-04-14 2011-04-11 Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki PL2557943T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1006178.6A GB201006178D0 (en) 2010-04-14 2010-04-14 Composition
PCT/GB2011/000557 WO2011128627A2 (en) 2010-04-14 2011-04-11 Oral veterinary pharmaceutical and nutraceutical compositions
EP11715599.4A EP2557943B1 (en) 2010-04-14 2011-04-11 Oral veterinary pharmaceutical and nutraceutical compositions

Publications (1)

Publication Number Publication Date
PL2557943T3 true PL2557943T3 (pl) 2018-10-31

Family

ID=42245160

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11715599T PL2557943T3 (pl) 2010-04-14 2011-04-11 Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki

Country Status (8)

Country Link
US (3) US20130273025A1 (pl)
EP (2) EP2557943B1 (pl)
JP (1) JP2013523871A (pl)
EA (1) EA025058B8 (pl)
ES (1) ES2680913T3 (pl)
GB (1) GB201006178D0 (pl)
PL (1) PL2557943T3 (pl)
WO (1) WO2011128627A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
HUE026168T2 (en) 2007-02-20 2016-05-30 Allergan Pharmaceuticals Int Ltd Stable digestive enzyme compositions
US10087493B2 (en) 2008-03-07 2018-10-02 Aptalis Pharma Canada Ulc Method for detecting infectious parvovirus in pharmaceutical preparations
GB0818473D0 (en) 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
ES2657673T3 (es) 2010-10-01 2018-03-06 Aptalis Pharma Limited Formulaciones recubiertas entéricas de pancrelipasa, de baja intensidad
CA2843556A1 (en) 2011-08-08 2013-02-14 Aptalis Pharma Ltd. Method for dissolution testing of solid compositions containing digestive enzymes
CN106163544A (zh) 2013-08-09 2016-11-23 阿勒根制药国际有限公司 适于经肠施用的消化酶组合物
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
EP3157568A1 (en) 2014-06-19 2017-04-26 Aptalis Pharma Limited Methods for removing viral contaminants from pancreatic extracts
KR102177029B1 (ko) * 2018-01-05 2020-11-10 (주)벨벳케어 애완동물 조제약 투약보조용 겔 유도형 조성물 및 그를 이용한 투약방법
CA3108738A1 (en) * 2018-09-21 2020-03-26 Societe Des Produits Nestle S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (epi)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2239954B1 (pl) * 1973-08-07 1978-06-09 Uncle Ben S Australia Pty
US4764383A (en) * 1985-10-21 1988-08-16 Michael Drebot Soft homogenous fish bait
DE19632455C1 (de) * 1996-08-12 1997-08-21 Cpc Maizena Gmbh Verfahren zur Herstellung eines Proteinhydrolysats aus proteinhaltigen tierischen Produkten
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
GB0229258D0 (en) * 2002-12-16 2003-01-22 Boots Healthcare Int Ltd Medicinal compositions
JP4026719B2 (ja) 2005-06-28 2007-12-26 本田技研工業株式会社 タペットクリアランス調整装置
EP1906925A1 (en) * 2005-07-28 2008-04-09 Teikoku Pharma USA, Inc. Gelled donepezil compositions and methods for making and using the same
GB0601498D0 (en) * 2006-01-25 2006-03-08 Probio Nutraceuticals As Product
GB0818472D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition
GB0818473D0 (en) * 2008-10-08 2008-11-12 Probio Nutraceuticals As Composition

Also Published As

Publication number Publication date
EA201290985A1 (ru) 2013-05-30
ES2680913T3 (es) 2018-09-11
WO2011128627A3 (en) 2012-05-03
US20170105992A1 (en) 2017-04-20
EA025058B8 (ru) 2017-02-28
US20190269677A1 (en) 2019-09-05
EP3138553A1 (en) 2017-03-08
US20130273025A1 (en) 2013-10-17
EP2557943A2 (en) 2013-02-20
EP2557943B1 (en) 2018-05-30
JP2013523871A (ja) 2013-06-17
EA025058B1 (ru) 2016-11-30
WO2011128627A2 (en) 2011-10-20
GB201006178D0 (en) 2010-06-02
WO2011128627A8 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
IL253870B (en) Certain amino-pyrimidines and pharmaceutical preparations containing them
PL2557943T3 (pl) Doustne weterynaryjne kompozycje farmaceutyczne i nutraceutyki
IL217912A (en) History of 5-Amino-1-Benzimidazole-Pyrazole and Pharmaceutical Preparations Containing It
IL222315A (en) Oral Pharmaceutical Preparations Containing Testosterone Endocrate
IL224976A (en) Converted history of 1h - indazole and a pharmaceutical preparation containing them
HK1164163A1 (zh) 半固態組合物和藥劑學產品
IL214911A0 (en) Solfonylated tetrahydroazolopyrazines and their use as medicinal products
EP2448406A4 (en) ORAL PHARMACEUTICAL COMPOSITIONS OF 3-HYDROXY-N-METHYLMORPHINAN WITH DELAYED RELEASE AND METHOD OF USE THEREOF
EP2395975A4 (en) ORAL PHARMACEUTICAL COMPOSITION OF DUTASTERIDE
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
PT2474522E (pt) Agomelatina e composições farmacêuticas que contêm a mesma
HK1183228A1 (zh) 口服藥物治療方法和組合物
IL221742A (en) Oral Pharmaceuticals Containing Debigtran Etxylate
HUE055771T2 (hu) Naproxén gyógyászati kiszerelései lágy gél kapszulázáshoz, és ezek kombinációi
ZA201200079B (en) Pharmaceutical compositions and solid forms
EP2560614A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THEIR ADMINISTRATION
RS61362B1 (sr) Farmaceutske formulacije loratadina za inkapsulaciju i njihove kombinacije
GB2504390B (en) Nutraceutical and pharmaceutical composition
ZA201104882B (en) Pharmaceutical compositions with superior product performance and patient compliance
PL2538955T3 (pl) Formulacja farmaceutyczna lub nutraceutyczna
IL226554A (en) Medicinal preparations containing alisporiovir
GB0902648D0 (en) Pharmaceutical compounds and compositions
PL2415463T3 (pl) Kompozycja lecznicza w postaci cząstek stałych
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
GB0908317D0 (en) Pharmaceutical compounds and compositions